NFE2L2 and ovarian cancer: Liu et al. 54 found that Nrf2 could activate the transsulfuration pathway by upregulating Cystathionine-β-synthase (CBS), a rate-limiting enzyme of the transsulfuration pathway 55, resulting in resistance of ovarian cancer cells to erastin-induced ferroptosis.